Michael E. Thase

47.3k total citations · 8 hit papers
563 papers, 30.9k citations indexed

About

Michael E. Thase is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, Michael E. Thase has authored 563 papers receiving a total of 30.9k indexed citations (citations by other indexed papers that have themselves been cited), including 319 papers in Pharmacology, 266 papers in Experimental and Cognitive Psychology and 139 papers in Psychiatry and Mental health. Recurrent topics in Michael E. Thase's work include Treatment of Major Depression (314 papers), Mental Health Research Topics (168 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (141 papers). Michael E. Thase is often cited by papers focused on Treatment of Major Depression (314 papers), Mental Health Research Topics (168 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (141 papers). Michael E. Thase collaborates with scholars based in United States, Canada and Germany. Michael E. Thase's co-authors include Greg J. Siegle, A. John Rush, John C. Markowitz, Susan G. Kornstein, Daniel N. Klein, Cameron S. Carter, Madhukar H. Trivedi, Stuart R. Steinhauer, James H. Kocsis and Rachel Manber and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Michael E. Thase

548 papers receiving 29.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

2003 3.0k citations Michael E. Thase et al. profile →
Frontiers of cognitive therapy

1997 808 citations Michael E. Thase profile →
Increased Amygdala and Decreased Dorsolateral Prefrontal BOLD Responses in Unipolar Depression: Related and Independent Features

2006 701 citations Michael E. Thase et al. profile →
Can’t shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals

2002 679 citations Michael E. Thase et al. profile →
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

2001 618 citations Michael E. Thase et al. profile →
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma

2003 569 citations Michael E. Thase, Alan F. Schatzberg et al. profile →
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression

2017 489 citations Richard C. Shelton, Michael E. Thase et al. profile →
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

2019 483 citations Michael E. Thase et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael E. Thase	11.6k	11.4k	8.5k	8.0k	6.0k	563	30.9k
M. Hamilton	7.8k 0.7×	6.8k 0.6×	7.8k 0.9×	10.6k 1.3×	6.0k 1.0×	15	28.8k
Stephen R. Wisniewski	7.7k 0.7×	13.0k 1.1×	7.8k 0.9×	13.3k 1.7×	4.1k 0.7×	492	42.6k
Siegfried Kasper	6.3k 0.5×	8.0k 0.7×	5.0k 0.6×	10.1k 1.3×	5.6k 0.9×	1.0k	34.8k
Stuart Montgomery	6.5k 0.6×	9.5k 0.8×	4.8k 0.6×	10.2k 1.3×	3.6k 0.6×	335	23.9k
Alan F. Schatzberg	7.7k 0.7×	7.4k 0.7×	5.0k 0.6×	6.8k 0.8×	10.8k 1.8×	421	34.1k
Guy M. Goodwin	6.6k 0.6×	5.4k 0.5×	6.7k 0.8×	14.3k 1.8×	9.0k 1.5×	476	35.0k
Jerrold F. Rosenbaum	5.9k 0.5×	6.7k 0.6×	6.6k 0.8×	6.6k 0.8×	2.4k 0.4×	258	20.0k
Alessandro Serretti	5.3k 0.5×	5.8k 0.5×	7.4k 0.9×	9.0k 1.1×	3.2k 0.5×	738	26.4k
Marie Åsberg	4.6k 0.4×	6.1k 0.5×	7.5k 0.9×	9.0k 1.1×	3.3k 0.5×	222	25.1k
David V. Sheehan	13.3k 1.1×	5.5k 0.5×	19.7k 2.3×	14.0k 1.8×	9.2k 1.5×	208	47.7k

Countries citing papers authored by Michael E. Thase

Since Specialization

Citations

This map shows the geographic impact of Michael E. Thase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Thase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Thase more than expected).

Fields of papers citing papers by Michael E. Thase

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Thase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Thase. The network helps show where Michael E. Thase may publish in the future.

Co-authorship network of co-authors of Michael E. Thase

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Thase. A scholar is included among the top collaborators of Michael E. Thase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Thase. Michael E. Thase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thase, Michael E.. (2023). Recent developments pertaining to treatment‐resistant depression: a 40‐year perspective. World Psychiatry. 22(3). 413–414. 2 indexed citations

Basner, Mathias, Hengyi Rao, Jennifer Goldschmied, et al.. (2023). 0199 Effects of acute sleep deprivation on cognitive performance in depressed individuals. SLEEP. 46(Supplement_1). A88–A89. 1 indexed citations

Thase, Michael E., et al.. (2023). Safety and Tolerability of Cariprazine for the Adjunctive Treatment of Major Depressive Disorder: A Pooled Analysis of Phase 2B and 3 Clinical Trials. CNS Spectrums. 28(2). 255–256. 1 indexed citations

Khazanov, Gabriela Kattan, Paige E. Morris, Shari Jager‐Hyman, et al.. (2022). Do financial incentives increase mental health treatment engagement? A meta-analysis.. Journal of Consulting and Clinical Psychology. 90(6). 528–544. 9 indexed citations

Perlis, Michael L., Knashawn H. Morales, Iván Vargas, et al.. (2021). The natural history of insomnia: Does sleep extension differentiate between those that do and do not develop chronic insomnia?. Journal of Sleep Research. 30(5). e13342–e13342. 8 indexed citations

Khazanov, Gabriela Kattan, Courtney N. Forbes, Barnaby D. Dunn, & Michael E. Thase. (2021). Addressing anhedonia to increase depression treatment engagement. British Journal of Clinical Psychology. 61(2). 255–280. 25 indexed citations

Thase, Michael E., et al.. (2015). Vortioxetine: a New Treatment for Major Depressive Disorder. Expert Opinion on Pharmacotherapy. 17(3). 421–431. 63 indexed citations

Thase, Michael E., Maurizio Fava, & Andrew A. Nierenberg. (2014). Depression: Addressing Partial Response After First-Line Antidepressant Treatment. The Journal of Clinical Psychiatry. 75(9). 978–980.

Schatzberg, Alan F., Pierre Blier, Larry Culpepper, et al.. (2014). An Overview of Vortioxetine. The Journal of Clinical Psychiatry. 75(12). 1411–1418. 22 indexed citations

10.

Thase, Michael E., Klaus Groes Larsen, Elin Heldbo Reines, & Sidney H. Kennedy. (2013). The cardiovascular safety profile of escitalopram. European Neuropsychopharmacology. 23(11). 1391–1400. 37 indexed citations

11.

Thase, Michael E.. (2013). Antidepressant Combinations: Cutting Edge Psychopharmacology or Passing Fad?. Current Psychiatry Reports. 15(10). 403–403. 9 indexed citations

12.

Wright, Jesse H., et al.. (2008). Aprendendo a terapia cognitivo-comportamental : um guia ilustrado. 42 indexed citations

13.

Thase, Michael E.. (2008). Remission is the optimal goal of acute phase antidpressant therapy. Actas Españolas de Psiquiatría. 36(1). 7–16. 2 indexed citations

14.

Thase, Michael E., et al.. (2007). Efficacy of Duloxetine and Selective Serotonin Reuptake Inhibitors. Journal of Clinical Psychopharmacology. 27(6). 672–676. 90 indexed citations

15.

Fava, Maurizio, Michael E. Thase, & Charles DeBattista. (2005). A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness. The Journal of Clinical Psychiatry. 66(1). 85–93. 141 indexed citations

16.

Shelton, Richard C., Martín Keller, Alan J. Gelenberg, et al.. (2001). Effectiveness of St John's wort in major depression: a randomized controlled trial.. PubMed. 285(15). 1978–86. 241 indexed citations

17.

Thase, Michael E., et al.. (2001). Efficacy of Mirtazapine for Prevention of Depressive Relapse. The Journal of Clinical Psychiatry. 62(10). 782–788. 65 indexed citations

18.

Salloum, Ihsan M., Dennis C. Daley, & Michael E. Thase. (2000). Male depression, alcoholism and violence. 7 indexed citations

19.

Thase, Michael E.. (1999). Summary: Defining Remission in Patients Treated With Antidepressants. 60. 35–36. 3 indexed citations

20.

Thase, Michael E., Charles F. Reynolds, Ellen Frank, & Anne D. Simons. (1994). Response to cognitive-behavioral therapy in chronic depression.. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact